
Ulrike Winkler Jenks
Examiner (ID: 11177)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1643, 1645 |
| Total Applications | 342 |
| Issued Applications | 157 |
| Pending Applications | 100 |
| Abandoned Applications | 85 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5967915
[patent_doc_number] => 20020090611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Detection of human immunodeficiency virus'
[patent_app_type] => new
[patent_app_number] => 10/044197
[patent_app_country] => US
[patent_app_date] => 2002-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5327
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20020090611.pdf
[firstpage_image] =>[orig_patent_app_number] => 10044197
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/044197 | Detection of human immunodeficiency virus | Jan 9, 2002 | Abandoned |
Array
(
[id] => 6800825
[patent_doc_number] => 20030095989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Chimeric cytolytic viruses for cancer treatment'
[patent_app_type] => new
[patent_app_number] => 10/023969
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8780
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20030095989.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023969
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023969 | Chimeric cytolytic viruses for cancer treatment | Dec 16, 2001 | Abandoned |
Array
(
[id] => 6697274
[patent_doc_number] => 20030109468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Novel compounds that enhance dimerization of the subunits of HIV-1 reverse transcriptase having mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/010129
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 27697
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109468.pdf
[firstpage_image] =>[orig_patent_app_number] => 10010129
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/010129 | Novel compounds that enhance dimerization of the subunits of HIV-1 reverse transcriptase having mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors | Dec 5, 2001 | Abandoned |
Array
(
[id] => 6062916
[patent_doc_number] => 20020031517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Methods for treating diabetes'
[patent_app_type] => new
[patent_app_number] => 09/988835
[patent_app_country] => US
[patent_app_date] => 2001-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11989
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20020031517.pdf
[firstpage_image] =>[orig_patent_app_number] => 09988835
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/988835 | Methods for treating diabetes | Nov 18, 2001 | Abandoned |
Array
(
[id] => 6378398
[patent_doc_number] => 20020119562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Method for selecting improved vectors'
[patent_app_type] => new
[patent_app_number] => 10/002598
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7427
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119562.pdf
[firstpage_image] =>[orig_patent_app_number] => 10002598
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/002598 | Method for selecting improved vectors | Nov 14, 2001 | Abandoned |
Array
(
[id] => 6778168
[patent_doc_number] => 20030049249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Agent'
[patent_app_type] => new
[patent_app_number] => 09/985164
[patent_app_country] => US
[patent_app_date] => 2001-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14202
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049249.pdf
[firstpage_image] =>[orig_patent_app_number] => 09985164
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/985164 | Agent | Oct 31, 2001 | Abandoned |
Array
(
[id] => 6534495
[patent_doc_number] => 20020137024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Methods for preparation of bioprosthetic tissue and implantable devices comprising such bioprosthetic tissue'
[patent_app_type] => new
[patent_app_number] => 10/004624
[patent_app_country] => US
[patent_app_date] => 2001-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14439
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137024.pdf
[firstpage_image] =>[orig_patent_app_number] => 10004624
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/004624 | Methods for preparation of bioprosthetic tissue and implantable devices comprising such bioprosthetic tissue | Oct 31, 2001 | Abandoned |
Array
(
[id] => 1080410
[patent_doc_number] => 06835568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-28
[patent_title] => 'Regulated nucleic acid expression system'
[patent_app_type] => B2
[patent_app_number] => 10/020472
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10166
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835568.pdf
[firstpage_image] =>[orig_patent_app_number] => 10020472
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/020472 | Regulated nucleic acid expression system | Oct 29, 2001 | Issued |
Array
(
[id] => 719463
[patent_doc_number] => 07049067
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Oligonucleotide for detection of HIV-1 and detection method'
[patent_app_type] => utility
[patent_app_number] => 09/984637
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5934
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049067.pdf
[firstpage_image] =>[orig_patent_app_number] => 09984637
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/984637 | Oligonucleotide for detection of HIV-1 and detection method | Oct 29, 2001 | Issued |
Array
(
[id] => 630560
[patent_doc_number] => 07132521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-07
[patent_title] => 'Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress'
[patent_app_type] => utility
[patent_app_number] => 10/046420
[patent_app_country] => US
[patent_app_date] => 2001-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12301
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/132/07132521.pdf
[firstpage_image] =>[orig_patent_app_number] => 10046420
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/046420 | Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress | Oct 25, 2001 | Issued |
Array
(
[id] => 1014811
[patent_doc_number] => 06894155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-17
[patent_title] => 'Nucleic acid molecules and polypeptides for immune modulation'
[patent_app_type] => utility
[patent_app_number] => 09/976605
[patent_app_country] => US
[patent_app_date] => 2001-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15433
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/894/06894155.pdf
[firstpage_image] =>[orig_patent_app_number] => 09976605
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/976605 | Nucleic acid molecules and polypeptides for immune modulation | Oct 10, 2001 | Issued |
Array
(
[id] => 6683132
[patent_doc_number] => 20030118996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Identification of virulence determinants activators in prokaryotic pathogens'
[patent_app_type] => new
[patent_app_number] => 09/971884
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11076
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20030118996.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971884
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971884 | Identification of virulence determinants activators in prokaryotic pathogens | Oct 4, 2001 | Abandoned |
Array
(
[id] => 6687923
[patent_doc_number] => 20030031648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Vectors for expressing heterologous peptides at the amino-terminus of potyvirus coat protein, methods for use thereof, plants infected with same and methods of vaccination using same'
[patent_app_type] => new
[patent_app_number] => 09/963761
[patent_app_country] => US
[patent_app_date] => 2001-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12208
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031648.pdf
[firstpage_image] =>[orig_patent_app_number] => 09963761
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/963761 | Vectors for expressing heterologous peptides at the amino-terminus of potyvirus coat protein, methods for use thereof, plants infected with same and methods of vaccination using same | Sep 26, 2001 | Abandoned |
| 09/831631 | Contraceptive antibody vaccines | Sep 20, 2001 | Abandoned |
Array
(
[id] => 773290
[patent_doc_number] => 07001767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-21
[patent_title] => 'Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies'
[patent_app_type] => utility
[patent_app_number] => 10/380800
[patent_app_country] => US
[patent_app_date] => 2001-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1860
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001767.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380800
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380800 | Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies | Sep 19, 2001 | Issued |
Array
(
[id] => 6715454
[patent_doc_number] => 20030026802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Novel methods for inhibition of HIV replication'
[patent_app_type] => new
[patent_app_number] => 09/961696
[patent_app_country] => US
[patent_app_date] => 2001-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 22095
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20030026802.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961696
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961696 | Methods for inhibition of HIV replication using a small molecule inhibitor | Sep 19, 2001 | Issued |
Array
(
[id] => 6628887
[patent_doc_number] => 20020086420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Novel antiangiogenic peptides'
[patent_app_type] => new
[patent_app_number] => 09/954968
[patent_app_country] => US
[patent_app_date] => 2001-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7864
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086420.pdf
[firstpage_image] =>[orig_patent_app_number] => 09954968
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/954968 | Antiangiogenic peptides and compositions thereof | Sep 17, 2001 | Issued |
Array
(
[id] => 6176276
[patent_doc_number] => 20020155562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Glutathionylspermidine synthetase and processes for recovery and use thereof'
[patent_app_type] => new
[patent_app_number] => 09/954433
[patent_app_country] => US
[patent_app_date] => 2001-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5735
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155562.pdf
[firstpage_image] =>[orig_patent_app_number] => 09954433
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/954433 | Glutathionylspermidine synthetase and processes for recovery and use thereof | Sep 16, 2001 | Abandoned |
Array
(
[id] => 6305959
[patent_doc_number] => 20020094522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS'
[patent_app_type] => new
[patent_app_number] => 09/953508
[patent_app_country] => US
[patent_app_date] => 2001-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 29513
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094522.pdf
[firstpage_image] =>[orig_patent_app_number] => 09953508
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/953508 | Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | Sep 13, 2001 | Abandoned |
Array
(
[id] => 1119491
[patent_doc_number] => 06797512
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-28
[patent_title] => 'Selection system for generating efficient packaging cells for lentiviral vectors'
[patent_app_type] => B1
[patent_app_number] => 09/831623
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2281
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/797/06797512.pdf
[firstpage_image] =>[orig_patent_app_number] => 09831623
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/831623 | Selection system for generating efficient packaging cells for lentiviral vectors | Sep 11, 2001 | Issued |